62 yr old DFU patient after 4 SoftWave sessions
MECHANISMS OF ACTION
• Modulates inflammation
• Increased blood supply
• Stimulates cytokines and growth factors
• Promotes Angiogenesis
• Wound epithelialization
• Tissue Regeneration
SoftWave produces a biological response that accelerates angiogenesis and revascularization which promotes faster wound healing.
Click on the above image to access our White Paper
SoftWave initiates a more rapid and effective healing phase.
It is thought to work by:
Extra Corporeal Shock Wave Therapy (EWST) has been widely used to treat a wide range of conditions, including complex and chronic non-healing soft tissue wounds with different etiologies, such as DFUs, peripheral arterial diseases, venous leg ulcers, and pressure ulcers.
ESWT has been demonstrated to positively impact the four stages of wound healing:
EWST is an adjunctive therapy that can be combined with standard wound care therapies.
ESWT is an evidence-based, non-invasive, convenient treatment for chronic wounds, including DFUs. One study found that using ESWT to treat chronic wounds resulted in nearly three-fourths (74.03%) of wounds closing and not reappearing in the same location.
Moreover, a meta-analysis that looked at five randomized studies implementing EWST across multiple types of wounds, including burns and DFUs, found a 20% absolute efficacy advantage for ESWT relative to control treatments and achievement of 50% of the performance goals outlined for ESWT effectiveness.
The SoftWave TRT patented, unfocused applicator design makes it possible to spread energy to a large treatment area to stimulate the body’s natural healing process and without microtrauma.
SoftWave therapy is typically a 10-minute treatment performed once a week for 6-8 weeks. SoftWave produces an unfocused shock wave which has the patented advantage of distributing maximum energy to a wide and deep area. This makes for reduced treatments and better outcomes.
Fast and easy to use
Used in an office/wound clinic/outpatient setting
Mobile unit fits seamlessly within wound care clinic
Does not require a sterile environment
Average treatment time is less than 10 minutes
Once-a-week treatment
Faster wound healing than standard of care
Non-invasive
Adjunct therapy can be used alone or in combination with other Advanced Wound Care
Decreases complications and amputation rates
FDA cleared to treat DFUs
Reimbursement Pathway with CPT codes 0512T and 0513T
Less costly than HBOT, NPWT, Skin Substitutes
Used at leading national and international research and medical centers as well as professional sports organizations such as:
